| A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement | Journal of Hepatology | 2020 | 764 |
| Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study | Lancet, The | 2020 | 472 |
| Colchicine in Patients with Chronic Coronary Disease | New England Journal of Medicine | 2020 | 396 |
| Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial | Lancet Oncology, The | 2020 | 140 |
| Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study | Lancet Respiratory Medicine,the | 2020 | 131 |
| Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project | JAMA - Journal of the American Medical Association | 2020 | 122 |
| A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study | Blood | 2020 | 110 |
| Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation | Hepatology | 2020 | 104 |
| The global burden of neurological disorders: translating evidence into policy | Lancet Neurology, The | 2020 | 95 |
| Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial | Lancet Oncology, The | 2020 | 80 |
| RONC-02. MEASURING THE EFFECT OF CLINICALLY-RELEVANT RADIOTHERAPY PROTOCOLS ON THE JUVENILE MOUSE BRAIN | Neuro-Oncology | 2020 | 78 |
| Conservative versus Interventional Treatment for Spontaneous Pneumothorax | New England Journal of Medicine | 2020 | 71 |
| International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis | Peritoneal Dialysis International | 2020 | 69 |
| Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial | BMJ, The | 2020 | 63 |
| Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial | Lancet Oncology, The | 2020 | 62 |
| Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic | Journal of Clinical Virology | 2020 | 56 |
| Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in | Lancet Oncology, The | 2020 | 53 |
| Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time? | Cancer Letters | 2020 | 49 |
| Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast Cancer | JAMA Oncology | 2020 | 45 |
| Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics | Genetics in Medicine | 2020 | 44 |
| Serum neurofilament light as a biomarker in progressive multiple sclerosis | Neurology | 2020 | 44 |
| 3-Year Freedom from Progression After Ga-PSMA PET/CT-Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter Trial | Journal of Nuclear Medicine | 2020 | 43 |
| TheraP: A randomised phase II trial of 177Lu-PSMA-617 (LuPSMA) theranostic versus cabazitaxel in metastatic castration resistant prostate cancer (mCRPC) progressing after docetaxel: Initial results (ANZUP protocol 1603). | Journal of Clinical Oncology | 2020 | 42 |
| Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis | Lancet Diabetes and Endocrinology,the | 2020 | 42 |
| Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis | Journal of Clinical Oncology | 2020 | 41 |
